GLA, the most abundant constituent of EPO, has anti-inflammatory effects through being converted to di-homo-γ-linoleic acid (DGLA) that stops the switching of AA to LT and the production of PGE-1, which plays important anti-inflammatory roles in RA [15, 55]. Here, EPO is linked to rheumatoid arthritis.